↓ Skip to main content

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.

Overview of attention for article published in Journal of Clinical Oncology, May 2000
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news
1 news outlet
guideline
1 clinical guideline source

Readers on

mendeley
34 Mendeley